Randall Brand, MD, Elected President of The Collaborative Group of the Americas on Inherited Colorectal Cancer
December 22, 2020
The Division of Gastroenterology, Hepatology and Nutrition’s Randall Brand, MD, has been elected the president of The Collaborative Group of the Americas on Inherited Colorectal Cancer (CGA-ICC).
The CGA-ICC aims to advance science and clinical care of inherited gastrointestinal (GI) cancers through research and education as the leading authority in the Americas.
About Dr. Brand
Dr. Brand is the academic director gastroenterology at UPMC Shadyside and the director of the Gastrointestinal Malignancy Early Detection, Diagnosis, and Prevention Program.
He is a physician-scientist with an extensive background in pancreatic diseases mainly focused on the early diagnosis of pancreatic cancer and cystic lesions of the pancreas.
He is also the leader of the University of Pittsburgh’s Pancreatic Adenocarcinoma Gene-Environment Registry (PAGER). The biospecimen repository developed as part of the PAGER study is nationally recognized and serves as an excellent resource for multiple NIH/NCI funded projects along with national and international collaborations with outside researchers.
He is a key contributor to the Early Detection Research Network, especially in research related to pancreatic cancer and cystic neoplasms and is currently funded in the network as a principal investigator to lead both a multi-center Pancreatic Cancer Clinical Validation Center and Biomarker Developmental Laboratory.
Dr. Brand’s clinical practice focuses on the management of pancreatic cancer, cystic lesions of the pancreas, and patients with other gastrointestinal cancers. He specializes in the management of individuals at high risk for the development of colon cancer, pancreatic cancer, and other GI malignancies.
